Following Robin Ferracone’s last TRUP Sell transaction on November 14, 2019, the stock climbed by 28.9%. This is Ferracone’s first Sell trade following 6 Buy transactions.
Based on Trupanion’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $111 million and GAAP net loss of -$1,133,000. In comparison, last year the company earned revenue of $92.2 million and had a GAAP net loss of $1.93 million. The company has a one-year high of $77.00 and a one-year low of $20.84. Currently, Trupanion has an average volume of 374.50K.
Based on 6 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $57.20, reflecting a 4.9% upside.
The insider sentiment on Trupanion has been negative according to 117 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Robin Ferracone’s trades have generated a 60.8% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members and contracts include multiple pets. The company was founded by Darryl Rawlings in January 2000 and is headquartered in Seattle, WA.